Identification of Hypoxia-Related Molecular Classification and Associated Gene Signature in Oral Squamous Cell Carcinoma

Código QR

Identification of Hypoxia-Related Molecular Classification and Associated Gene Signature in Oral Squamous Cell Carcinoma

The high heterogeneity of oral squamous cell carcinoma (OSCC) is the main obstacle for individualized treatment. Recognizing the characteristics of different subtypes and investigating the promising strategies for each subclass are of great significance in precise treatment. In this study, we system...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen Li, Xin Chen, Xiaolin Ren, Jia-lin Chen, Hao Chen, Jing-jia Yu, Qiu-chi Ran, Shuang Kang, Xi-meng Chen, Zhen-jin Zhao
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	oral squamous cell carcinoma (OSCC) hypoxia subtyping immune microenvironment immunotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/048ae32b187941b294d967b0e620ab87
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

p53 Immunoexpression in Oral Squamous Cell Carcinomas from Different Anatomical Sites: A Comparative Study
por: Sá,Cláudia T., et al.
Publicado: (2006)

Silmitasertib-induced macropinocytosis promoting DDP intracellular uptake to enhance cell apoptosis in oral squamous cell carcinoma
por: Shaojuan Song, et al.
Publicado: (2021)

Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma
por: Wei Z, et al.
Publicado: (2018)

Characterization of Recurrent Relevant Genes Reveals a Novel Role of RPL36A in Radioresistant Oral Squamous Cell Carcinoma
por: Ting-Wen Chen, et al.
Publicado: (2021)

Acantholytic Squamous Cell Carcinoma
por: Sandy Maganito, et al.
Publicado: (2021)

Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Pingfei Tang, et al.
Publicado: (2021)

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
por: Jiao Hu, et al.
Publicado: (2021)

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
por: Jiannan Yao, et al.
Publicado: (2021)

Worst Pattern of Perineural Invasion Redefines the Spatial Localization of Nerves in Oral Squamous Cell Carcinoma
por: Yong Fu, et al.
Publicado: (2021)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021)

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
por: Agarwal,A. K, et al.
Publicado: (2011)

Assessment of Tumor Associated Tissue Eosinophilia (TATE) in Oral Squamous Cell Carcinoma Using Carbol Chromotrope Stain
por: Peter,Celestina Dawn, et al.
Publicado: (2015)

4NQO Carcinogenesis: A Model of Oral Squamous Cell Carcinoma
por: Rivera Martínez,César Andrés
Publicado: (2012)

Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
por: Madison Pereira, et al.
Publicado: (2021)

Oral Squamous Cell Carcinoma Associated with Arsenic Exposure: A Case Series from Argentina
por: Leonardi,Nicolás, et al.
Publicado: (2020)

Immunoexpression of p53 in Oral Squamous Cell Carcinoma and Oral Dysplastic Lesions in Patients with the Habit of Reverse Smoke
por: Álvarez Martínez,Efraín, et al.
Publicado: (2013)

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
por: Patricia Martin-Romano, et al.
Publicado: (2021)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Mengxue Zhang, et al.
Publicado: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Xinwen Wang, et al.
Publicado: (2021)

Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening
por: Tao Yan, et al.
Publicado: (2021)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
por: Gunnar Wichmann, et al.
Publicado: (2021)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Jinhui Liu, et al.
Publicado: (2021)

Host Immune Response Triggered by Graphene Quantum-Dot-Mediated Photodynamic Therapy for Oral Squamous Cell Carcinoma
por: Zhang X, et al.
Publicado: (2020)

Immunoexpression of Cell Proliferation Markers in Oral Squamous Cell Carcinoma
por: Pereira,Joabe dos Santos, et al.
Publicado: (2016)

Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
por: He Jian, et al.
Publicado: (2021)

Long non-coding RNA LINC01207 promotes cell proliferation and migration but suppresses apoptosis and autophagy in oral squamous cell carcinoma by the microRNA-1301-3p/lactate dehydrogenase isoform A axis
por: Xiaolin Lu, et al.
Publicado: (2021)

A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer
por: Xianwu Chen, et al.
Publicado: (2021)

The Value of Model Based on Radiomics Features of T2-weighted Imaging and Clinical Feature in Diagnosing the Depth of Stromal Invasion of Cervical Squamous Cell Carcinoma
por: REN Jing, et al.
Publicado: (2021)

Pigmented Squamous Cell Carcinoma: Is the Reported Prevalence Real?
por: Paola Corneli, et al.
Publicado: (2019)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian X, et al.
Publicado: (2021)

The Oral Mouse Microbiome Promotes Tumorigenesis in Oral Squamous Cell Carcinoma
por: Philip Stashenko, et al.
Publicado: (2019)

Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
por: Jacob D. Siegel, MD, et al.
Publicado: (2021)

Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Nader Aboul-Fettouh, et al.
Publicado: (2021)

Morphometric Analysis of Nucleus and Nucleolar Organizer Regions (NORs) in Tongue Squamous Cell Carcinoma (SCC)
por: Padovani,J. A. Jr., et al.
Publicado: (2007)

Evaluation of specifity and sensitivity of AgNORs in oral squamous cell carcinoma & epithelial dysplasia
por: M Seyyed Majidi, et al.
Publicado: (2005)

Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
por: Iago Ferreira, et al.
Publicado: (2021)

Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma
por: Ping Zhou, et al.
Publicado: (2021)

Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
por: Shalini K. Sureshbabu, et al.
Publicado: (2021)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
por: Song C, et al.
Publicado: (2020)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ying-Peng Peng, et al.
Publicado: (2021)